Scenario.press - libera espressione Scenario.press - libera espressione
Search Results
See All Results
  • Join
    Sign In
    Sign Up
    Search
    Night Mode

Search

Discover new people, create new connections and make new friends

  • News Feed
  • EXPLORE
  • Pages
  • Groups
  • Events
  • Blogs
  • Marketplace
  • Funding
  • Offers
  • Jobs
  • Courses
  • Movies
  • Developers
  • Posts
  • Blogs
  • Users
  • Pages
  • Groups
  • Events
  • jerry001 added blog Networking
    2025-01-30 05:34:57 -
    Carglumic Acid Dispersible Tablets Market | Industry Analysis, Emerging Demands and Forecast to 2031 | Recordati Rare Diseases, Grand Pharmaceutical Group, Sovereign Medical
    Carglumic Acid Dispersible Tablets Market report has recently added by Analytic Insights Hub which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. Carglumic Acid Dispersible Tablets Market study goes...
    0 Comments 0 Shares 2K Views
    Please log in to like, share and comment!
  • akshayg added blog Other
    2025-04-08 12:47:15 -
    Carglumic Acid Market, Comprehensive Analysis Reveals Superb Growth by Fact MR
    ​The global carglumic acid market is experiencing significant growth, driven by factors such as the rising prevalence of metabolic disorders, advancements in drug formulations, and increased awareness of rare diseases. Carglumic acid, derived from N-acetyl glutamate, plays a crucial role in detoxifying ammonia in the human body by activating the first enzyme in the urea cycle. It is...
    0 Comments 0 Shares 1K Views
    Please log in to like, share and comment!
  • akshayg added blog Networking
    2024-06-18 18:23:28 -
    What Are the Environmental Considerations in Carglumic Acid Production?
    Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation...
    0 Comments 0 Shares 4K Views
    Please log in to like, share and comment!
© 2025 Scenario.press - libera espressione English
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Privacy Business Model Donations Contact Us Directory